FindTrial
Sign In

SB11 PFS

COMBINATION_PRODUCT2 trials

Sponsors

Samsung Bioepis Co., Ltd.

Conditions

Age-Related Macular DegenerationBranch Retinal Vein Occlusion With Macular EdemaCentral Retinal Vein Occlusion With Macular EdemaMacular EdemaMyopic Choroidal NeovascularizationNeovascular Age-related Macular DegenerationRetinal Vein Occlusion

Phase 2

A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO
CompletedNCT06176963
Samsung Bioepis Co., Ltd.Macular Edema, Neovascular Age-related Macular Degeneration, Retinal Vein Occlusion
Start: 2023-11-21End: 2023-12-12Updated: 2024-12-30
A Study to Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNV
CompletedNCT07550504
Samsung Bioepis Co., Ltd.Age-Related Macular Degeneration, Branch Retinal Vein Occlusion With Macular Edema, Central Retinal Vein Occlusion With Macular Edema +1
Start: 2026-03-30End: 2026-04-09Updated: 2026-04-24

Related Papers

Usability of the SB11 Pre-filled Syringe (PFS) in Patients with Retinal Diseases
Advances in Therapy2024-07-083 citations